Abstract
Background: SARS-CoV-2 uses angiotensin-converting enzyme 2 (ACE2) as a receptor for entering the host cells. Production of the ACE2 molecule is important because of its potency to use as a blocker and therapeutic agent against SARS-CoV-2 for the prophylaxis and treatment of COVID-19.
Objective: The recombinant human ACE2 (rhACE2) is prone to form an inclusion body when expressed in the bacterial cells.
Methods: We used the SUMO tag fused to the rhACE2 molecule to increase the expression level and solubility of the fusion protein. Afterward, the freeze-thawing method plus 2 M urea solubilized aggregated proteins. Subsequently, the affinity of solubilized rhACE2 to the receptor binding domain (RBD) of the SARS-CoV-2 spike was assayed by ELISA and SPR methods.
Results: SUMO protein succeeded in increasing the expression level but not solubilization of the fusion protein. The freeze-thawing method could solubilize and recover the aggregated fusion proteins significantly. Also, ELISA and SPR assays confirmed the interaction between solubilized rhACE2 and RBD with high affinity.
Conclusion: The SUMO tag and freeze-thawing method would be utilized for high-level expression and solubilization of recombinant rhACE2 protein.
Keywords: ACE2, inclusion body, mild solubilization, RBD, SARS-CoV-2, SUMO tag, rhACE2.
[http://dx.doi.org/10.1038/s41586-020-2012-7] [PMID: 32015507]
[http://dx.doi.org/10.1101/2020.02.17.952903]
[http://dx.doi.org/10.1073/pnas.2016093117] [PMID: 33093202]
[http://dx.doi.org/10.1023/B:JSFG.0000029237.70316.52] [PMID: 15263846]
[http://dx.doi.org/10.1110/ps.051812706] [PMID: 16322573]
[http://dx.doi.org/10.1016/j.pep.2005.02.004] [PMID: 15939295]
[http://dx.doi.org/10.1186/s12934-015-0208-6] [PMID: 25879903]
[http://dx.doi.org/10.1038/s41594-020-00549-3] [PMID: 33432247]
[http://dx.doi.org/10.1126/science.1116480] [PMID: 16166518]
[http://dx.doi.org/10.12688/f1000research.22211.2] [PMID: 32117569]
[http://dx.doi.org/10.1007/s40262-013-0072-7] [PMID: 23681967]
[http://dx.doi.org/10.1186/s13054-017-1823-x] [PMID: 28877748]
[http://dx.doi.org/10.1016/j.pep.2021.105889] [PMID: 33852951]
[http://dx.doi.org/10.1016/S2213-2600(20)30418-5] [PMID: 33131609]
[http://dx.doi.org/10.1016/j.cell.2020.04.004] [PMID: 32333836]
[http://dx.doi.org/10.1186/1475-2859-5-S1-P61]
[http://dx.doi.org/10.1016/j.jmb.2004.09.076] [PMID: 15544807]
[http://dx.doi.org/10.1016/j.jmb.2003.11.053] [PMID: 14741208]
[http://dx.doi.org/10.1006/abbi.2000.2088] [PMID: 11368330]
[http://dx.doi.org/10.1002/bit.10612] [PMID: 12673768]
[http://dx.doi.org/10.1038/s41598-020-71188-3] [PMID: 32848162]
[http://dx.doi.org/10.7554/eLife.70658] [PMID: 34435953]